Medical cost, incidence rate, and treatment status of gastroesophageal reflux disease in Japan: analysis of claims data

References

• Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-20
   PubMed Web of Science ®Google Scholar
• Velanovich V. Quality of life and severity of symptoms in gastro-oesophageal reflux disease: a clinical review. Eur J Surg 2000;166:516-25
   PubMedGoogle Scholar
• Prasad M, Rentz AM, Revicki DA. The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review. Pharmacoeconomics 2003;21:769-90
   PubMed Web of Science ®Google Scholar
• Joish VN, Donaldson G, Stockdale W, et al. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 2005;21:535-44
   PubMed Web of Science ®Google Scholar
• Xiong LS, Cui Y, Wang JP, et al. Prevalence and risk factors of Barrett's esophagus in patients undergoing endoscopy for upper gastrointestinal symptoms. J Dig Dis 2010;11:83-7
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Talley NJ, Storskrubb T, et al. Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study. Am J Gastroenterol 2011;106:1946-52
   PubMed Web of Science ®Google Scholar
• Lagergren J, Bergström R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31
   PubMed Web of Science ®Google Scholar
• Pera M. Trends in incidence and prevalence of specialized intestinal metaplasia, barrett's esophagus, and adenocarcinoma of the gastroesophageal junction. World J Surg 2003;27:999-1008
   PubMed Web of Science ®Google Scholar
• Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J Gastroenterol 2009;44:518-34
   PubMed Web of Science ®Google Scholar
• Miwa H, Oshima T, Tomita T, et al. Gastro-esophageal reflux disease: the recent trend in Japan. Clin J Gastroenterol 2008;1:133-38
   PubMedGoogle Scholar
• Manabe N, Haruma K, Kamada T, et al. Changes of upper gastrointestinal symptoms and endoscopic findings in Japan over 25 years. Intern Med 2011;50:1357-63
   PubMed Web of Science ®Google Scholar
• Ronkainen J, Agréus L. Epidemiology of reflux symptoms and GORD. Best Pract Res Clin Gastroenterol 2013;27:325-37
   PubMed Web of Science ®Google Scholar
• Nilsson M, Johnsen R, Ye W, et al. Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut 2004;53:1730-35
   PubMed Web of Science ®Google Scholar
• Nocon M, Labenz J, Willich SN. Lifestyle factors and symptoms of gastro-oesophageal reflux - a population-based study. Aliment Pharmacol Ther 2006;23:169-74
   PubMed Web of Science ®Google Scholar
• Murphy DW, Castell DO. Chocolate and heartburn: evidence of increased esophageal acid exposure after chocolate ingestion. Am J Gastroenterol 1988;83:633-36
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Satia JA, Rabeneck L. Dietary intake and the risk of gastrooesophageal reflux disease: a cross sectional study in volunteers. Gut 2005;54:11-17
   PubMed Web of Science ®Google Scholar
• Gastroesophageal reflux disease (GERD) clinical practice guidelines 2015 Revision 2 [In Japanese]. Tokyo, Japan: The Japanese Society of Gastroenterology, 2015
   Google Scholar
• Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol 2013;108:308-23
   PubMed Web of Science ®Google Scholar
• Habu Y, Maeda K, Kusuda T, et al. “Proton-pump inhibitor-first” strategy versus “step-up” strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan. J Gastroenterol 2005;40:1029-35
   PubMed Web of Science ®Google Scholar
• Suzuki H, Matsuzaki J, Masaoka T, et al. Greater loss of productivity among Japanese workers with gastro-esophageal reflux disease (GERD) symptoms that persist vs resolve on medical therapy. Neurogastroenterol Motil 2014;26:764-71
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare [Japan]. Statistical classification of diseases and cause of death [In Japanese]. Tokyo, Japan: Ministry of Health, Labour and Welfare, 2003. http://www.mhlw.go.jp/toukei/sippei/. Accessed January 22, 2016
   Google Scholar
• Moki F, Kusano M, Mizuide M, et al. Association between reflux oesophagitis and features of the metabolic syndrome in Japan. Aliment Pharmacol Ther 2007;26:1069-75
   PubMed Web of Science ®Google Scholar
• Yagi S, Okada H, Takenaka R, et al. Influence of Helicobacter pylori eradication on reflux esophagitis in Japanese patients. Dis Esophagus 2009;22:361-7
   PubMed Web of Science ®Google Scholar
• Nakajima S, Nishiyama Y, Yamaoka M, et al. Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years. J Gastroenterol Hepatol 2010;25(1 Suppl):S99-S110
   Google Scholar
• Kinoshita Y, Kawanami C, Kishi K, et al. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut 1997;4:452-8
   Google Scholar
• Sakaguchi M, Oka H, Hashimoto T, et al. Obesity as a risk factor for GERD in Japan. J Gastroenterol 2008;43:57-62
   PubMed Web of Science ®Google Scholar
• Adachi K, Mishiro T, Tanaka S, et al. Gender differences in the time-course changes of reflux esophagitis in Japanese patients. Intern Med 2015;54:869-73
   PubMed Web of Science ®Google Scholar
• Ministry of Health, Labour and Welfare [Japan]. Medical cost of the general population in Japan in 2013 [In Japanese]. Tokyo, Japan: Ministry of Health, Labour and Welfare, 2015. http://www.e-stat.go.jp/SG1/estat/GL08020103.do?_toGL08020103_&listID =000001138601. Accessed January 25, 2016
   Google Scholar
• Katz PO, Zavala S. Proton Pump Inhibitors in the Management of GERD. J Gastrointest Surg 2010;14 (1 Suppl):S62-S6
   Google Scholar
• Hvid-Jensen F, Nielsen RB, Pedersen L, et al. Lifestyle factors among proton pump inhibitor users and nonusers: a cross-sectional study in a population-based setting. Clin Epidemiol 2013;5:493-9
   PubMedGoogle Scholar